TREM1作为一种新的预后生物标志物和瘤免疫微环境评估器在质瘤中

Qin Lu1, Yonglin Xie2, Xuchen Qi1

  • 1Department of Neurosurgery, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China.

Medicine
|December 5, 2023
PubMed
概括

在骨髓细胞1 (TREM1) 上表达的触发受体在质瘤中升高,与预后不佳和晚期疾病相关. 这种免疫调节器影响瘤微环境,为诊断和预后生物标志物提供潜力.